Antimicrobial sensitivity in a large US multicenter trial of rabeprazole-based triple therapy for H. pylori eradication

被引：0
|
作者：
Vakil, N
Jayanty, V
Stanton, D
Perdomo, C
Hahne, W
Barth, J
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
63
引用
收藏
页码：A9 / A9
页数：1
相关论文
共 50 条
  • [1] Antimicrobial resistance as a cause of failed H-pylori eradication:: Results of a US multicenter trial of rabeprazole-based triple therapy
    Vakil, N
    Jayanty, V
    Stanton, D
    Perdomo, C
    Hahne, W
    Barth, J
    [J]. GUT, 2002, 51 : A93 - A93
  • [2] Rabeprazole-based triple therapy is safe and well tolerated in Helicobacter pylori eradication:: Findings from a large us multicenter trial
    Lanza, F
    Kovacs, T
    Hahne, W
    Barth, J
    Sontag, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S24 - S24
  • [3] Clarithromycin resistance and H pylori eradication rates in US racial groups with rabeprazole-based triple therapy
    Vakil, N
    Perdomo, C
    Barth, J
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A360 - A361
  • [4] Randomized controlled trial of rabeprazole, levofloxacin and rifabutin triple therapy versus rabeprazole-based quadruple therapy as a rescue treatment after failure of Helicobacter pylori (H. pylori) eradication with standard triple therapies
    Wong, WM
    Gu, Q
    Lam, SK
    Fung, FMY
    Lai, KC
    Xia, HHX
    Hu, WHC
    Wong, BCY
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A587 - A587
  • [5] A prospective, controlled, randomized trial of 3-, 7-, and 10-day rabeprazole-based triple therapy for H. pylori eradication in the USA
    Vakil, N
    Schwartz, HJ
    Lanza, FL
    Nardi, L
    Hahne, W
    Barth, J
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A65 - A65
  • [6] 7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: Are they still effective ? A randomized trial
    Karatapanis, S.
    Georgopoulos, S. D.
    Papastergiou, V.
    Skorda, L.
    Papantoniou, N.
    Lisgos, Ph.
    Kouvidou, C.
    Fragkou, P.
    Mentis, A.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2011, 74 (03) : 407 - 412
  • [7] Review article:: rabeprazole-based therapy in Helicobacter pylori eradication
    Barth, J
    Hahne, W
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 : 31 - 33
  • [8] Rabeprazole-based eradication therapy for Helicobacter pylori:: a large-scale study in Japan
    Kuwayama, H.
    Asaka, K.
    Sugiyama, T.
    Fukuda, Y.
    Aoyama, N.
    Hirai, Y.
    Fujioka, T.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (09) : 1105 - 1113
  • [9] Racial demographics do not affect efficacy of rabeprazole-based, triple therapy for Helicobacter pylori eradication
    Vakil, N
    Schwartz, H
    Perdomo, C
    Barth, J
    Sontag, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S17 - S17
  • [10] Consistent Helicobacter pylori eradication rates with rabeprazole-based triple therapy across demographic subgroups
    Vakil, N
    Stanton, D
    Hahne, W
    Barth, J
    Kovacs, T
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S21 - S21
12345